Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
cyc116 aurora kinase a small molecule Clinical trial target TTD , drugbank , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA investigational,phase 1 inhibitor
cyc116 aurora kinase a small molecule Clinical trial target TTD , drugbank , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA investigational,phase 1 unknown
cyc116 aurora kinase b NA Clinical trial target TTD , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA phase 1 inhibitor
cyc116 aurora kinase b NA Clinical trial target TTD , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA phase 1 unknown
cyc116 vascular endothelial growth factor receptor 2 small molecule Successful target TTD , drugbank , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA investigational,phase 1 unknown
click here to return to the previous page